Graphite Bio, Inc.

Graphite Bio, Inc.verified

GRPH

Price:

$3.18

Market Cap:

$204.43M

Graphite Bio, Inc. is a clinical-stage gene editing company dedicated to developing innovative therapeutic solutions for severe and life-threatening illnesses across the United States. Its primary investigational therapy, GPH101, is an autologous, gene-edited hematopoietic stem cell product specifically engineered to directly correct the underlying mutation causing sickle cell disease, thereby restoring normal adult hemoglobin production. The company's pipeline also features GPH201, intended for the treatment of X-linked severe combined immunodeficiency syndrome, and GPH301, an experimental candidate designed to address Gaucher disease, a genetic disorder characterized by a deficiency in the...[Read more]

Industry

Biotechnology

IPO Date

2021-06-25

Stock Exchange

NASDAQ

Ticker

GRPH

The Current Ratio as of June 2026 (TTM) for Graphite Bio, Inc. (GRPH) is 10.40

According to Graphite Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.40. This represents a change of -27.56% compared to the average of 14.36 of the last 4 quarters.

Graphite Bio, Inc. (GRPH) Historical Current Ratio (quarterly & annually)

How has GRPH Current Ratio performed in the past?

The mean historical Current Ratio of Graphite Bio, Inc. over the last ten years is 8.28. The current 10.40 Current Ratio has changed 12.45% with respect to the historical average. Over the past ten years (40 quarters), GRPH's Current Ratio was at its highest in in the June 2021 quarter at 48.96. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

8.28

Median

4.91

Minimum

0.00

Maximum

20.36

Graphite Bio, Inc. (GRPH) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Graphite Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 24.31%

Maximum Annual Current Ratio = 20.36

Minimum Annual Increase = -66.42%

Minimum Annual Current Ratio = 0.00

Quarterly (TTM)
Annual
YearCurrent RatioChange
202513.80-32.24%
202420.36460.70%
20233.63-26.03%
20224.91-66.42%
202114.622.12%
20200.6624.31%

Graphite Bio, Inc. (GRPH) Average Current Ratio

How has GRPH Current Ratio performed in the past?

The current Current Ratio of Graphite Bio, Inc. (GRPH) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

12.60

5-year avg

11.47

10-year avg

8.28

Graphite Bio, Inc. (GRPH) Current Ratio vs. Peers

How is GRPH’s Current Ratio compared to its peers?

Graphite Bio, Inc.’s Current Ratio is less than Theseus Pharmaceuticals, Inc. (17.79), greater than LakeShore Biopharma Co., Ltd (1.02), greater than Vaccitech plc (6.05), greater than Zevra Therapeutics, Inc. (4.89), greater than Alaunos Therapeutics, Inc. (1.63), less than CARGO Therapeutics, Inc. Common Stock (12.37), greater than Spectrum Pharmaceuticals, Inc. (2.37), greater than F-star Therapeutics, Inc. (6.98), greater than Graybug Vision, Inc. (1.61), greater than eXoZymes, Inc. (1.32),

Build a custom stock screener for Graphite Bio, Inc. (GRPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graphite Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Graphite Bio, Inc. (GRPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Graphite Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Graphite Bio, Inc.'s Current Ratio?

How is the Current Ratio calculated for Graphite Bio, Inc. (GRPH)?

What is the highest Current Ratio for Graphite Bio, Inc. (GRPH)?

What is the 3-year average Current Ratio for Graphite Bio, Inc. (GRPH)?

What is the 5-year average Current Ratio for Graphite Bio, Inc. (GRPH)?

How does the current Current Ratio for Graphite Bio, Inc. (GRPH) compare to its historical average?